SCHEMBL21787995

SCHEMBL21787995

COc1ccc(N(N)c2ccc3c(c2)C(C)(C)c2ccccc2-3)cc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ PDK2 Q15119 3/20 0.38
▸ KDM4E B2RXH2 5/20 0.35
▸ LMNA P02545 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ PGR P06401 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ HTR7 P34969 2/20 0.33
▸ GAA P10253 2/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PTPRC P08575 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21787757 0.89 MAOA (0.39) MAOAMAOBPDK2KDM4ELMNA
SCHEMBL24177663 0.87 GAA (0.40) PDK2KDM4ELMNASMN1; SMN2ALDH1A1
SCHEMBL21787758 0.86 MAOA (0.37) MAOAMAOBPDK2KDM4ELMNA
SCHEMBL21787743 0.84 MAOA (0.46) MAOAMAOBKDM4ELMNASMN1; SMN2
SCHEMBL17886997 0.83 PDK2 (0.39) PDK2LMNASMN1; SMN2L3MBTL1MEN1
SCHEMBL21787751 0.83 PDK2 (0.39) PDK2LMNASMN1; SMN2L3MBTL1MEN1
SCHEMBL12703005 0.83 PDK2 (0.43) PDK2KDM4ELMNASMN1; SMN2PGR
SCHEMBL21787832 0.82 PDK2 (0.37) PDK2ALDH1A1PGRHSD17B10
SCHEMBL21416352 0.81 PDK2 (0.43) PDK2PGR
SCHEMBL24177579 0.81 PDK2 (0.40) PDK2KDM4ELMNASMN1; SMN2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2022-01-06 — — US disclosed
EP-3650438-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2020-05-13 — — EP disclosed
US-20200075862-A1 INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2020-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS NR0B2, KCNJ2, TRRAP MAOA 172/4885MAOB 113/4885PDK2 1160/4885
US-20200075862-A1 INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS KCNJ2, KCNA2, CYP2J2 MAOA 45/4885MAOB 40/4885PDK2 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback